UEG
4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol
| Created: | 2013-09-12 |
| Last modified: | 2024-09-27 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 23 |
| Chiral Atom Count | 0 |
| Bond Count | 23 |
| Aromatic Bond Count | 6 |
Chemical Component Summary | |
|---|---|
| Name | 4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol |
| Systematic Name (OpenEye OEToolkits) | 4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol |
| Formula | C8 H11 N O3 |
| Molecular Weight | 169.178 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | Oc1c(c(cnc1C)CO)CO |
| SMILES | CACTVS | 3.385 | Cc1ncc(CO)c(CO)c1O |
| SMILES | OpenEye OEToolkits | 1.9.2 | Cc1c(c(c(cn1)CO)CO)O |
| Canonical SMILES | CACTVS | 3.385 | Cc1ncc(CO)c(CO)c1O |
| Canonical SMILES | OpenEye OEToolkits | 1.9.2 | Cc1c(c(c(cn1)CO)CO)O |
| InChI | InChI | 1.03 | InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3 |
| InChIKey | InChI | 1.03 | LXNHXLLTXMVWPM-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB00165 |
|---|---|
| Name | Pyridoxine |
| Description | Pyridoxine is the 4-methanol form of vitamin B6, an important water-soluble vitamin that is naturally present in many foods. As its classification as a vitamin implies, Vitamin B6 (and pyridoxine) are essential nutrients required for normal functioning of many biological systems within the body. While many plants and microorganisms are able to synthesize pyridoxine through endogenous biological processes, animals must obtain it through their diet. More specifically, pyridoxine is converted to pyridoxal 5-phosphate in the body, which is an important coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid. It's important to note that Vitamin B6 is the collective term for a group of three related compounds, pyridoxine, pyridoxal, and pyridoxamine, and their phosphorylated derivatives, pyridoxine 5'-phosphate, pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate. Although all six of these compounds should technically be referred to as vitamin B6, the term vitamin B6 is commonly used interchangeably with just one of them, pyridoxine [A32836]. Vitamin B6, principally in its biologically active coenzyme form pyridoxal 5'-phosphate, is involved in a wide range of biochemical reactions, including the metabolism of amino acids and glycogen, the synthesis of nucleic acids, hemogloblin, sphingomyelin and other sphingolipids, and the synthesis of the neurotransmitters serotonin, dopamine, norepinephrine and gamma-aminobutyric acid (GABA) [A32837]. Pyridoxine is used medically for the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy (due to [DB00951]'s mechanism of action which competitively inhibits the action of pyridoxine in the above-mentioned metabolic functions). It is also used in combination with [DB00366] (as the commercially available product Diclectin) for the treatment of nausea and vomiting in pregnancy. |
| Synonyms |
|
| Indication | Pyridoxine is indicated for the treatment of vitamin B6 deficiency and for the prophylaxis of [DB00951]-induced peripheral neuropathy. It is also approved by Health Canada for the treatment of nausea and vomiting in pregnancy in a combination product with [DB00366] (as the commercially available product Diclectin). |
| Categories |
|
| ATC-Code |
|
| CAS number | 65-23-6 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Pyridoxal kinase | MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYA... | unknown | ligand |
| Cytochrome P450 1A1 | MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG... | unknown | inhibitor |
| Pyridoxal kinase | MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYA... | unknown | substrate |
| Pyridoxal phosphate phosphatase | MARCERLRGAALRDVLGRAQGVLFDCDGVLWNGERAVPGAPELLERLARA... | unknown | substrate |
| Alkaline phosphatase, tissue-nonspecific isozyme | MISPFLVLAIGTCLTNSLVPEKEKDPKYWRDQAQETLKYALELQKLNTNV... | unknown | substrate |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 1054 |
| ChEMBL | CHEMBL1364 |
| ChEBI | CHEBI:16709 |
| CCDC/CSD | BITZAF |














